MELISSA HARE: Open Payments
NPI 1285389163 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,077 in 126 payments from 17 companies in 2025. Trend: 2023 $22 · 2024 $1,378 · 2025 $2,077
Food & beverage: $2,077
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $415 |
| ABBVIE INC. | 24 | $365 |
| Ardelyx, Inc. | 13 | $235 |
| Lilly USA, LLC | 13 | $209 |
| Madrigal Pharmaceuticals | 8 | $153 |
| Regeneron Healthcare Solutions, Inc. | 7 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $122 |
| Aimmune Therapeutics, Inc. | 5 | $103 |
| Phathom Pharmaceuticals, Inc. | 11 | $71 |
| Braintree Laboratories, Inc. | 3 | $64 |
Products named: TREMFYA, IBSRELA, OMVOH, RINVOQ, REZDIFFRA, DUPIXENT, ZENPEP, ENTYVIO.
Industry payments across SC — which companies pay providers there.
